The Journal of Drug Development and Biomedicine ( JDDB )

The Journal of Drug Development and Biomedicine is a scientific publication dedicated to the dissemination of research in the fields of pharmaceutical sciences, drug development, and biomedicine. It serves as a platform for researchers, scientists, and clinicians to share their latest findings and advancements in the understanding and development of novel therapeutic agents, drug delivery systems, and biomedical innovations.

Editor in Chief: Dr. Md. Saiful Islam Khan

BSc (Hon’s), MSc (Plant Biotechnology), Doctor of Philosophy (Shizuoka University, Japan)

The Journal of Drug Development and Biomedicine is a scientific publication dedicated to the dissemination of research in the fields of pharmaceutical sciences, drug development, and biomedicine. It serves as a platform for researchers, scientists, and clinicians to share their latest findings and advancements in the understanding and development of novel therapeutic agents, drug delivery systems, and biomedical innovations.

Aim and Scope

The journal of Drug Development and Biomedicine is an open-access journal that promotes drug development and biomedical science. It publishes original research articles, reviews, and clinical studies that investigate the discovery, design, development, and evaluation of pharmacological and biotechnological molecules

The journal’s focus is to communicate high-quality, methodologically sound research that advances our understanding and knowledge of drug development and biomedical sciences. It accepts submissions in the following areas:

  • Drug Discovery and Design: Innovations in the identification and design of new therapeutic agents.
  • Pharmacology: Studies on the biological effects and mechanisms of action of drugs.
  • Pharmacokinetics and Pharmacodynamics: Research on the absorption, distribution, metabolism, excretion, and effects of drugs.
  • Drug Delivery Systems: Development of novel methods for the targeted and controlled delivery of drugs.
  • Biotechnology: Advancements in the use of biological systems and organisms in drug development.
  • Clinical Trials and Studies: Clinical evaluations of new drugs and therapeutic interventions.

By focusing on these topics, the journal seeks to bridge the gap between laboratory research and clinical application, thereby promoting the development of effective and safe therapeutic solutions.

Publication Ethics

The Journal of Drug Development and Biomedicine is committed to sustaining the highest levels of publication ethics, assuring the integrity and quality of the research it publishes. While precise information regarding this journal’s ethical standards is not easily available, journals in this discipline are known to follow established ethical norms and practices.

Many respected journals adhere to the Committee on Publication Ethics’ (COPE) core standards, which provide detailed recommendations for editors and publishers on how to address incidents of research and publication misconduct.

Furthermore, publications frequently follow the International Committee of Medical Journal Editors’ (ICMJE) recommendations, which stress the roles of authors, editors, and reviewers in upholding ethical standards. Common ethical considerations in reputable journals include:

  • Authorship and Contribution: Ensuring that all listed authors contributed significantly to the research and manuscript preparation.
  • Conflict of Interest: Authors, reviewers, and editors must state any potential conflicts of interest that may have an impact on the study or review process.
  • Data Integrity: Requiring correct reporting of study findings without fabrication, falsification, or improper data manipulation.
  • Plagiarism Prevention: Requiring correct reporting of study findings without fabrication, falsification, or improper data manipulation.
  • Ethical Research Conduct: All study involving human or animal participants must adhere to relevant ethical standards and obtain proper clearances.

Policies and Statements

The journal of Drug Development and Biomedicine is an open access journal that focuses on quality pharmaceutical discoveries and developments. It publishes research reports, review articles, and scientific commentaries on a wide range of pharmaceutical sciences topics, including medicinal chemistry, pharmacology, drug absorption and metabolism, pharmacokinetics and pharmacodynamics, pharmaceutical and biomedical analysis, drug delivery systems, pharmaceutical technology, biotechnology, and clinical drug evaluation.

Editorial Policies:

Open Access: JDDB operates under an open-access model, which implies that all published content is freely available to readers.

Review Process: The journal maintains high-quality manuscripts through a rigorous review process. Experts in the field assess articles to ensure their scientific validity and application.

Ethical Guidelines: When conducting research and publishing, authors must adhere to ethical rules. Comprehensive standards are proposed to ensure respect to moral values.

Submission and Contact Information: Authors can submit manuscripts through the journal’s submission portal or via email to the Editorial Office at editor@imedpub.com.

Editorial Workflow

The editorial workflow of the Journal of Drug Development and Biomedicine is typically designed to assure the publication of high-quality research. While the details can vary substantially from journal to journal, the general approach generally comprises the following steps:

  1. Manuscript Submission

Author’s Responsibility: The method begins when an author submits a work for consideration. The manuscript is frequently submitted via an email submission system.

Pre-submission Checks: The editing team conducts a preliminary check to confirm compliance with submission standards, formatting, and ethical considerations.

  1. Initial Editorial Assessment

Editor’s Review: The managing editor, who is typically a plant protection expert, does a preliminary assessment. This review assesses the manuscript’s suitability for publication based on its relevance to the journal’s scope, scientific quality, and novelty.

Decision Making: The editor determines whether to forward the manuscript for review, reject it entirely, or seek adjustments for resubmission.

  1. Review

Selection of Reviewers: If the document passes the initial review, it is assigned to other peer reviewers. The editor selects reviewers based on their plant protection experience, ensuring a fair and objective review process.

Review Process: Reviewers evaluate the manuscript’s scientific validity, methods, findings, and contribution to the area. They provide feedback on the manuscript’s merits, weaknesses, and potential areas for improvement.

Reviewer Comments: After completing the review, the reviewers submit their comments to the editor. Depending on the research’s quality and originality, feedback can range from minor revisions to rejection.

  1. Decision on Manuscript

Editor’s Decision: The editor decides on the content depending on the reviewers’ feedback. Common choices are:

Accept: If the manuscript is deemed acceptable with no minor adjustments.

Minor Revisions: Minor adjustments are requested from the authors in order to improve the work.

Major Revisions: Significant changes or clarifications are necessary, and the document is re-evaluated after alterations.

Reject: If the work is rejected for publication due to errors in approach, analysis, or relevance.

Notification to Authors: The decision and the reviewer comments are relayed to the authors. The writers make any necessary adjustments to their article.

  1. Revisions and Resubmission

Author’s Role: In a revised publication, the authors address the reviewers’ comments and recommendations. They may need to revise their interpretation of the results, clarify some aspects of the approach, or provide further data.

Resubmission: The corrected document has been sent back for review. It may occasionally be returned for a second evaluation by the original reviewers or new reviewers.

  1. Final Acceptance

Final Review: Following the completion of all modifications, the editor does a final review of the manuscript to ensure that all of the reviewers’ concerns have been handled appropriately.

Acceptance: The manuscript is accepted for publication if it meets the journal’s criteria.

  1. Proofreading and Copyediting

Production Process: Following acceptance, the manuscript is proofread and copyedited to ensure that it is clear, consistent, and meets the journal’s formatting and style criteria.

Author Approval: The authors may be asked to review the revised paper for any final changes or adjustments.

  1. Publication

Online First: Following final approval, the paper is made available online, either in early release or as a preprint.

Issue Publication: After that, the work is published in a regular issue of the journal, either online or in print.

  1. Post-Publication

Promotion: To enhance reading and citation, the journal may promote the paper on social media, email newsletters, or through other outreach tactics. Throughout the workflow, transparency, rigor, and commitment to ethical norms are critical to the journal’s credibility and effect.

Article Processing Charge

The Article Processing Charge (APC) for the Journal of Drug Development and Biomedicine is a fee that covers the costs of the editorial process, review, and open access publication. This fee guarantees that publications are freely accessible to readers globally without the need for a subscription, enabling the wider distribution and impact of research findings. The APC is normally assessed after the manuscript has been accepted following the peer-review process. The APC for each article is US$50.

Manuscript submission

The Journal of Drug Development and Biomedicine is an open access journal dedicated to publishing high-quality research in the fields of pharmaceutical sciences, biomedical advancements, and interdisciplinary studies related to drug discovery and development. Researchers and academics are encouraged to contribute original manuscripts, reviews, case studies, and short communications.

Manuscript Submission Guidelines

Scope of Submission

The journal accepts manuscripts covering topics such as:

Drug design, synthesis, and discovery

Pharmacokinetics and pharmacodynamics studies

Biomedical research advancements

Clinical trials and their methodologies

Innovative drug delivery systems

Biotechnological approaches in drug development

Pharmaceutical chemistry and toxicology

Preparation of Manuscripts

Format: Manuscripts should be submitted in English, formatted as per the journal’s guidelines.

Structure:

Title Page: Title, authors’ names, affiliations, and corresponding author contact details.

Abstract: A concise summary of the research, limited to 250 words.

Keywords: 4–6 relevant keywords.

Main Text: Divided into Introduction, Materials and Methods, Results, Discussion, Conclusion, and References sections.

References: Follow the journal’s citation style (usually Vancouver or APA). Use reference management software for accuracy.

Figures and Tables: Include high-resolution figures and well-formatted tables with appropriate captions.

Ethical Considerations

Manuscripts should adhere to ethical standards, ensuring proper approvals for animal or human studies.

Authors must disclose any conflicts of interest.

The journal has a strict policy against plagiarism. Submissions are screened using plagiarism detection software.

Submission Process

Submissions are made online through the journal’s email submission system.

Authors must register on the platform, upload their manuscripts in the prescribed format, and provide supplementary documents like cover letters and coppy right agreement certificates.

Review Process

The journal follows a double-blind peer review

Authors may suggest potential reviewers, but the editorial board reserves the right to make final decisions.

Post-Acceptance

Once accepted, manuscripts undergo professional editing and formatting.

Authors receive galley proofs for final approval before publication.

Publication Fees

Details on article processing charges (APC), are provided on the journal’s website.

Open Access and Visibility

The journal offers open-access publication to ensure global reach and visibility for the authors’ work.

Benefits of Publishing with the Journal

Fast and transparent review process.

Opportunities for cross-disciplinary collaboration.